Hepatocellular Carcinoma Clinical Trials in Beijing
17 recruitingBeijing, China
Showing 1–17 of 17 trials
Recruiting
Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech246 enrolled51 locationsNCT07176650
Recruiting
Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Biliary Tract CancerHepatocellular Carcinoma
AstraZeneca294 enrolled60 locationsNCT05775159
Recruiting
Phase 1
A Phase I Study of CREPT-618 in Locally Advanced HCC
Hepatocellular Carcinoma (HCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences13 enrolled1 locationNCT07364357
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2
Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca114 enrolled24 locationsNCT07081633
Recruiting
Phase 2
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital300 enrolled1 locationNCT07157969
Recruiting
Phase 2
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore100 enrolled14 locationsNCT05377034
Recruiting
Phase 3
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Radiotherapy, AdjuvantHepatocellular Carcinoma (HCC)Immune Checkpoint Inhibitor+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences286 enrolled1 locationNCT07186621
Recruiting
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
Hepatocellular Carcinoma (HCC)Microvascular Invasion (MVI)
Chinese Academy of Sciences400 enrolled19 locationsNCT07170345
Recruiting
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Primary Liver Cancer
Peking Union Medical College Hospital308 enrolled1 locationNCT07101237
Recruiting
Phase 1
Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
Lion TCR Pte. Ltd.10 enrolled1 locationNCT06961617
Recruiting
The Overall Survival of Patients With Unresectable HCC in Real-life
Hepatocellular Carcinoma
Humanity & Health Medical Group Limited5,000 enrolled3 locationsNCT03612726
Recruiting
Phase 3
Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma
Hepatocellular Carcinoma
AstraZeneca210 enrolled32 locationsNCT05557838
Recruiting
Phase 1
Mts105 for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)HCC - Hepatocellular CarcinomaLiver Cancer, Adult+1 more
Shen Lin14 enrolled1 locationNCT06689540
Recruiting
Phase 1Phase 2
Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma
Hepatocellular Carcinoma
Beijing 302 Hospital20 enrolled1 locationNCT06463522
Recruiting
Phase 2
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.
Hepatocellular CarcinomaRadiotherapyNarrow Margin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences100 enrolled1 locationNCT06205472
Recruiting
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis
Hepatocellular Carcinoma
Beijing 302 Hospital60 enrolled1 locationNCT04512833